Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group
儿童肿瘤协作组的一项报告显示,在长春新碱、放线菌素D和环磷酰胺的基础上加用长春新碱和伊立替康并不能改善中危横纹肌肉瘤的预后。
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2018.77.9694
Hawkins, Douglas S; Chi, Yueh-Yun; Anderson, James R; Tian, Jing; Arndt, Carola A S; Bomgaars, Lisa; Donaldson, Sarah S; Hayes-Jordan, Andrea; Mascarenhas, Leo; McCarville, Mary Beth; McCune, Jeannine S; McCowage, Geoff; Million, Lynn; Morris, Carol D; Parham, David M; Rodeberg, David A; Rudzinski, Erin R; Shnorhavorian, Margarett; Spunt, Sheri L; Skapek, Stephen X; Teot, Lisa A; Wolden, Suzanne; Yock, Torunn I; Meyer, William H